| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||||||||
Net cash provided by (used in) operating activities | ||||||||||||
1,548 | 1,828 | 2,888 | 2,854 | 3,147 | 3,062 | 2,862 | 3,088 | 3,327 | 3,396 | 0 | 0 | 0 |
Cash flows from investing activities | ||||||||||||
Sales, maturities and repayments of fixed maturity securities | ||||||||||||
11,720 | 14,146 | 16,027 | 17,320 | 15,862 | 15,819 | 16,110 | 17,906 | 18,047 | 17,214 | 0 | 0 | 0 |
Sales, maturities and repayments of equity securities | ||||||||||||
65 | 57 | 36 | 26 | 22 | 22 | 54 | 69 | 78 | 97 | 0 | 0 | 0 |
Sales, maturities and repayments of mortgage loans | ||||||||||||
1,756 | 1,538 | 1,284 | 1,040 | 891 | 797 | 623 | 672 | 767 | 742 | 0 | 0 | 0 |
Sales, maturities and repayments of real estate limited partnerships and limited liability companies | ||||||||||||
- | - | - | - | - | - | 0 | 0 | 140 | - | 0 | 0 | 0 |
Sales, maturities and repayments of limited partnerships and limited liability companies | ||||||||||||
294 | 302 | 341 | 343 | 310 | 275 | 283 | 264 | 273 | 341 | 0 | 0 | 0 |
Purchases of fixed maturity securities | ||||||||||||
15,626 | 16,915 | 17,867 | 18,329 | 16,486 | 16,460 | 17,899 | 18,645 | 20,012 | 18,782 | 0 | 0 | 0 |
Purchases of equity securities | ||||||||||||
- | - | - | - | - | 2 | 1 | 1 | 0 | 2 | 0 | 0 | 0 |
Purchases of mortgage loans | ||||||||||||
2,813 | 3,610 | 3,744 | 3,947 | 4,227 | 3,890 | 3,258 | 2,761 | 2,158 | 2,041 | 0 | 0 | 0 |
Purchases of real estate limited partnerships and limited liability companies | ||||||||||||
- | - | - | - | - | - | 0 | 0 | 248 | - | 0 | 0 | 0 |
Purchases of limited partnerships and limited liability companies | ||||||||||||
531 | 463 | 472 | 459 | 430 | 358 | 551 | 521 | 512 | 531 | 0 | 0 | 0 |
Cash received in connection with freestanding derivatives | ||||||||||||
5,137 | 2,041 | 1,840 | 1,806 | 1,407 | 1,803 | 1,196 | 819 | 1,267 | 1,865 | 0 | 0 | 0 |
Cash paid in connection with freestanding derivatives | ||||||||||||
4,136 | 2,639 | 2,359 | 2,711 | 1,836 | 2,940 | 2,735 | 2,680 | 3,395 | 3,831 | 0 | 0 | 0 |
Net change in policy loans | ||||||||||||
-134 | -129 | -111 | -117 | -132 | -103 | -80 | -55 | 4 | 6 | 0 | 0 | 0 |
Net change in short-term investments | ||||||||||||
3,530 | 1,942 | 1,861 | 612 | 506 | -312 | -1,046 | -1,122 | -778 | -1,030 | 0 | 0 | 0 |
Net change in other invested assets | ||||||||||||
1 | -37 | 33 | -26 | -14 | 19 | 11 | 11 | 10 | 13 | 0 | 0 | 0 |
Net cash provided by (used in) investing activities | ||||||||||||
-7,553 | -7,341 | -6,768 | -5,447 | -4,907 | -4,538 | -4,830 | -3,577 | -4,796 | -3,915 | 0 | 0 | 0 |
Cash flows from financing activities | ||||||||||||
Policyholder account balances: Deposits | ||||||||||||
7,788 | 7,672 | 7,465 | 7,256 | 6,822 | 6,480 | 6,230 | 5,798 | 5,327 | 4,990 | 0 | 0 | 0 |
Policyholder account balances: Withdrawals | ||||||||||||
2,416 | 2,849 | 3,316 | 3,431 | 3,633 | 3,494 | 3,033 | 3,079 | 2,856 | 3,103 | 0 | 0 | 0 |
Net change in payables for collateral under securities loaned and other transactions | ||||||||||||
6,998 | -666 | 1,248 | -171 | -254 | 888 | -526 | -2,855 | -2,933 | -3,147 | 0 | 0 | 0 |
Long-term debt issued | ||||||||||||
0 | 1,000 | 1,000 | 1,375 | 1,375 | 375 | 0 | 0 | 0 | - | - | - | - |
Long-term debt repaid | ||||||||||||
2 | 602 | 601 | 604 | 606 | 9 | 12 | 12 | 13 | 13 | 0 | 0 | 0 |
Preferred stock issued, net of issuance costs | ||||||||||||
0 | 412 | 412 | 412 | 412 | 0 | 0 | 0 | 0 | - | - | - | - |
Dividends on preferred stock | ||||||||||||
28 | 21 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Treasury stock acquired in connection with share repurchases | ||||||||||||
532 | 442 | 377 | 293 | 157 | 105 | 0 | 0 | 0 | - | - | - | - |
Cash received from MetLife, Inc. in connection with shareholder’s net investment | ||||||||||||
- | - | - | - | - | - | - | - | - | 293 | 0 | 0 | 0 |
Cash paid to MetLife, Inc. in connection with shareholder’s net investment | ||||||||||||
- | - | - | - | - | - | - | - | - | 668 | 0 | 0 | 0 |
Financing element on certain derivative instruments and other derivative related transactions, net | ||||||||||||
678 | 203 | -262 | 33 | 157 | 303 | 498 | 421 | 530 | 149 | 0 | 0 | 0 |
Other, net | ||||||||||||
-59 | -56 | -54 | -65 | -66 | -68 | -79 | -52 | -64 | -48 | 0 | 0 | 0 |
Net cash provided by (used in) financing activities | ||||||||||||
11,071 | 4,245 | 6,025 | 4,439 | 3,736 | 3,764 | 2,414 | -1,819 | -2,455 | -2,852 | 0 | 0 | 0 |
Change in cash, cash equivalents and restricted cash | ||||||||||||
5,066 | -1,268 | 2,145 | 1,846 | 1,976 | 2,288 | 446 | -2,308 | -3,924 | -3,371 | 0 | 0 | 0 |
Supplemental disclosures of cash flow information | ||||||||||||
Net cash paid (received) for interest | ||||||||||||
190 | 187 | 184 | 171 | 163 | 159 | 149 | 146 | 129 | 155 | 0 | 0 | 0 |
Net cash paid (received) for income tax | ||||||||||||
17 | 16 | -890 | -893 | -896 | -895 | -710 | -679 | -644 | -637 | 0 | 0 | 0 |
Non-cash transactions: | ||||||||||||
Transfer of fixed maturity securities to former affiliate | ||||||||||||
- | - | - | - | - | - | - | - | - | 293 | 0 | 0 | 0 |
Reduction of policyholder account balances in connection with reinsurance transactions | ||||||||||||
- | - | - | - | - | - | - | - | - | 293 | 0 | 0 | 0 |